No proof HIV antibodies are caused by a retroviral infection
Eleni Papadopulos-Eleopulos
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this authorValendar F Turner
West Australian Department of Health, Perth, and
Search for more papers by this authorBarry AP Page
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this authorJohn Papadimitriou
University of Western Australia, Crawley, Western Australia, Australia http://www.theperthgroup.com
Search for more papers by this authorDavid Causer
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this authorEleni Papadopulos-Eleopulos
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this authorValendar F Turner
West Australian Department of Health, Perth, and
Search for more papers by this authorBarry AP Page
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this authorJohn Papadimitriou
University of Western Australia, Crawley, Western Australia, Australia http://www.theperthgroup.com
Search for more papers by this authorDavid Causer
Department of Medical Physics, Royal Perth Hospital,
Search for more papers by this author
References
- 1 Curry C, Bunungam P, Annerud C, Babona D. HIV antibody seroprevalence in the emergency department at Port Moresby General Hospital, Papua New Guinea. Emerg. Med. Australas 2005; 17: 359–62.
- 2 Tahi D. Did Luc Montagnier discover HIV? Text of video interview with Professor Luc Montagnier at the Pasteur Institute July 18th 1997. Continuum 1998; 5: 30–4. Available from URL: http://www.theperthgroup.com/CONTINUUM/djamelmontagnier.html[Accessed October 2005].
- 3 Berzofsky JA, Berkower IJ, Epstein SL. Antigen–antibody interactions and monoclonal antibodies. In: WE Paul (ed.). Fundamental Immunology, 3rd edn. New York: Raven, 1993; 421–65.
- 4 St. Louis ME, Rauch KJ, Peterson LR, Anderson JE, Schable CA, Dondero TJ. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. N. Engl. J. Med. 1990; 323: 213–18.
- 5 Baskar PV, Collins GD, Dorsey-Cooper BA et al. Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clin. Exp. Immunol. 1998; 111: 251–6.
- 6 Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D. HIV antibodies: further questions and a plea for clarification. Curr. Med. Res. Opin. 1997; 13: 627–34. Available from URL: http://www.theperthgroup.com/SCIPAPERS/epcurmedres97.html[Accessed October 2005].
- 7 Kashala O, Marlink R, Ilunga M et al. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J. Infect. Dis 1994; 169: 296–304.
- 8
Griner PF,
Mayewski RJ,
Mushlin AI.
Selection and interpretation of diagnostic tests and procedures.
Ann. Int. Med.
1981; 94: 559–63.
10.7326/0003-4819-94-4-559 Google Scholar
- 9 Abbott Laboratories Diagnostics Division. 100 Abbott Park Rd. Abbott Park, IL, USA. 1988, 1998. Packet Insert Axsym system (HIV-1/HIV-2). Available from URL: http://aids-kritik.de/aids/diverses/abbott-hiv-test.htm[Accessed October 2005].
